U.S. Home Infusion Therapy Market Size, Share & Trends Analysis By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-Infective, Endocrinology), And Segment Forecasts, 2022 - 2030

U.S. Home Infusion Therapy Market Size, Share & Trends Analysis By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-Infective, Endocrinology), And Segment Forecasts, 2022 - 2030

U.S. Home Infusion Therapy Market Growth & Trends

The U.S. home infusion therapy market size is expected to reach USD 31.7 billion by 2030, registering a CAGR of 7.5% during the forecast period, according to a new report by Grand View Research, Inc. The growing geriatric population and increasing prevalence of cancer, Crohn's disease, multiple sclerosis, nutritional and immune deficiencies, infections, dehydration, and nausea & vomiting are majorly driving the growth of the market. Factors such as the increasing need for reduced hospital stays and the rising prevalence of chronic disorders in the geriatric population are driving the growth.

Growing cases of Hospital Acquired Infections (HAI) are also driving the growth of the market for home infusion therapy in the U.S. According to the U.S. Centers for Disease Control and Prevention (CDC), annually, approximately 1.7 million admitted patients are affected by Healthcare Acquired infections (HCAI) and around 98, 000 patients (1 in 17 patients) die due to the same. Due to this, the demand for home infusion therapy is increasing substantially.

Increasing innovations in home infusion therapy such as the incorporation of Electronic Healthcare Records (EHR) along with medical devices and infusion pumps are trending. Electronic healthcare records allow storage, retrieval, and alteration of medical records, making it easier for healthcare professionals and patients to track improvements in a particular disorder.

Increasing preference for home healthcare among patients due to the cost-efficiency compared to hospital stays is an opportunity for the industry players to launch more innovative products. Also, the introduction of safety products will ultimately help the growth of the market.

The COVID-19 outbreak boosted the growth of the home infusion market in the country as many key players like Baxter; BD; ICU Medical; and Option Care Health, Inc. reported revenue increases for their home infusion products and services in 2020. This trend is expected to further boost the growth as numerous healthcare settings in the country are expected to permanently opt for home infusion services to decrease the patient admission burden in hospitals and other healthcare facilities.

U.S. Home Infusion Therapy Market Report Highlights

  • The infusion pumps segment held a larger share of the market in comparison to others due to increasing use and efficiency in delivering required quantities of nutrition, medications, and other essential fluids
  • Needleless connectors is expected to be the fastest-growing segment owing to various benefits, such as less risk of bacterial contamination and higher protection against needle stick injuries
  • The anti-infective segment held the largest revenue share of the U.S. market for home infusion therapy in 2021 owing to its extensive use as antifungal, antibiotics, and antiviral agents at-home care
  • Endocrinology is predicted to be the fastest-growing segment owing to the growing number of conditions associated with the endocrine system, such as thyroid and diabetes
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective 1
1.8.2 Objective 2
1.8.3 Objective 3
1.8.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Penetration & Growth Prospect Mapping
2.3 Market Dynamics
2.3.1 Market Driver Analysis
2.3.1.1 Increasing geriatric population
2.3.1.2 Rising prevalence of chronic disorders
2.3.1.3 Rapid technological advancements
2.3.1.4 Growing incidence of hospital acquired infections
2.3.1.5 Home healthcare as cost effective alternative
2.3.2 Market Restrain Analysis
2.3.2.1 Presence of complicated reimbursement framework and reimbursement cuts
2.3.3 Impact Of The 21st Century Cures Act And Projections For The Impact Of The Bipartisan Budget Act Of 2018.
2.3.4 Trends For Home Infusion For Medicare Part B And Medicare Part D
2.4 Home Infusion Therapy: Market Analysis Tools
2.4.1 Industry Analysis - Porter’s
2.4.2 PESTEL Analysis
2.5 U.S Home Infusion Therapy- Company Market Share Analysis 2018
2.6 Major Deals & Strategic Alliances Analysis
2.7 Procedure cost analysis/breakdown
2.8 Technology Timeline
2.9 Regulatory Framework
2.10 Reimbursement framework
Chapter 3 Home Infusion Therapy Market: Segment Analysis, By Product, 2017 - 2030 (USD Million)
3.1 Product Market Share Analysis, 2021 & 2030
3.2 U.S. Home Infusion Therapy Market, by Product, 2021 to 2030
3.3 Market Size & Forecasts and Trend Analyses, 2021 to 2030
3.3.1 Infusion Pumps
3.3.2 Intravenous Sets
3.3.3 Iv Cannulas
3.3.4 Needleless Connectors
Chapter 4 Home Infusion Therapy Market: Segment Analysis, By Application, 2017 - 2030 (USD Million)
4.1 Application Market Share Analysis, 2021 & 2030
4.2 U.S. Home Infusion Therapy Market, by Application, 2021 to 2030
4.3 Market Size & Forecasts and Trend Analyses, 2021 to 2030
4.3.1 Anti-Infective
4.3.1.1 Anti-infective market, 2017 - 2030 (USD Million)
4.3.2 Endocrinology
4.3.2.1 Endocrinology Market, 2017 - 2030 (USD Million)
4.3.2.2 Diabetes market, 2017 - 2030 (USD Million)
4.3.2.3 Others market, 2017 - 2030 (USD Million)
4.3.3 Hydration Therapy
4.3.3.1 hydration therapy market, 2017 - 2030 (USD Million)
4.3.3.2 Athletes market, 2017 - 2030 (USD Million)
4.3.3.3 Others market, 2017 - 2030 (USD Million)
4.3.4 Chemotherapy
4.3.4.1 Chemotherapy Market, 2017 - 2030 (USD Million)
4.3.5 Enteral Nutrition
4.3.5.1 Enteral Nutrition Market, 2017 - 2030 (USD Million)
4.3.6 Parenteral Nutrition
4.3.6.1 Parenteral Nutrition Market, 2017 - 2030 (USD Million)
4.3.7 Specialty Pharmaceuticals
4.3.7.1 Specialty Pharmaceuticals Market, 2017 - 2030 (USD Million)
4.3.8 Others
4.3.8.1 Others market, 2017 - 2030 (USD Million)
Chapter 5 Home Infusion Therapy Market: Country Market Analysis, By Product, 2017 - 2030 (USD Million)
5.1 Market Size, & Forecasts and Trend Analysis, 2021 to 2030
5.2 U.S.
5.2.1 U.S. Home Infusion Therapy Market, By Product, 2017 - 2030 (USD Million)
5.2.2 U.S. Home Infusion Therapy Market, By Appliction, 2017 - 2030 (USD Million)
Chapter 6 Home Infusion Therapy Market - Competitive Analysis
6.1 Competitive Dashboard Analysis - Impact Analysis
6.1.1 Recent Developments & Impact Analysis, By Key Market Participants
6.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
6.2.1 List of Key Innovators
6.2.2 List of Market Leader
6.2.3 List of Emerging Players
6.3 Company market position analysis (Revenue, product portfolio, key serviceable industries, key alliances)
6.3.1 By Revenue
6.4 Strategy Framework
6.5 Company Profiles
6.5.1 B. Braun Melsungen AG
6.5.1.1 Company overview
6.5.1.2 Financial performance
6.5.1.3 Product benchmarking
6.5.1.4 Strategic initiatives
6.5.2 Baxter
6.5.2.1 Company overview
6.5.2.2 Financial performance
6.5.2.3 Product benchmarking
6.5.2.4 Strategic initiatives
6.5.3 Caesarea Medical Electronics
6.5.3.1 Company overview
6.5.3.2 Product benchmarking
6.5.3.3 Strategic initiatives
6.5.4 Carefusion Corporation
6.5.4.1 Company overview
6.5.4.2 Financial performance
6.5.4.3 Product benchmarking
6.5.4.4 Strategic initiatives
6.5.5 Fresenius Kabi AG
6.5.5.1 Company overview
6.5.5.2 Financial performance
6.5.5.3 Product benchmarking
6.5.5.4 Strategic initiatives
6.5.6 ICU Medical, Inc.
6.5.6.1 Company overview
6.5.6.2 Financial performance
6.5.6.3 Product benchmarking
6.5.6.4 Strategic initiatives
6.5.7 JMS Co., Ltd.
6.5.7.1 Company overview
6.5.7.2 Financial performance
6.5.7.3 Product benchmarking
6.5.8 Smiths Medical
6.5.8.1 Company overview
6.5.8.2 Financial performance
6.5.8.3 Product benchmarking
6.5.8.4 Strategic initiatives
6.5.9 Terumo Corporation
6.5.9.1 Company overview
6.5.9.2 Financial performance
6.5.9.3 Product benchmarking
6.5.9.4 Strategic initiatives
6.5.10 Coram LLC
6.5.10.1 Company overview
6.5.10.2 Product benchmarking
6.5.11 Option Care Enterprises, Inc.
6.5.11.1 Company overview
6.5.11.2 Financial performance
6.5.11.3 Product benchmarking
6.5.11.4 Strategic initiatives
6.5.12 Bioscrip, Inc.
6.5.12.1 Company overview
6.5.12.2 Financial performance
6.5.12.3 Product benchmarking
6.5.12.4 Strategic initiatives
6.5.13 Briovarx Infusion Services
6.5.13.1 Company overview
6.5.13.2 Financial performance
6.5.13.3 Product benchmarking
6.5.13.4 Strategic initiatives
6.6.14 Paragon Healthcare, Inc.
6.6.14.1 Company overview
6.6.14.2 Financial performance
6.6.14.3 Product benchmarking

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings